PARA vs. PFE
Compare and contrast key facts about Paramount Global Class B (PARA) and Pfizer Inc. (PFE).
Performance
PARA vs. PFE - Performance Comparison
Loading graphics...
PARA vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PARA Paramount Global Class B | 0.00% | 6.45% | -27.96% | -10.43% | -41.80% | -17.17% | -7.58% | -2.34% | -24.86% | -6.17% |
PFE Pfizer Inc. | 14.66% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Fundamentals
PARA:
$12.23B
PFE:
$159.66B
PARA:
-$0.65
PFE:
$1.36
PARA:
0.37
PFE:
2.56
PARA:
1.05
PFE:
1.72
PARA:
$28.89B
PFE:
$62.58B
PARA:
$8.54B
PFE:
$44.01B
PARA:
$2.64B
PFE:
$15.10B
Returns By Period
PARA
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PFE
- 1D
- 1.12%
- 1M
- 1.56%
- YTD
- 14.66%
- 6M
- 14.02%
- 1Y
- 18.86%
- 3Y*
- -6.22%
- 5Y*
- -0.14%
- 10Y*
- 4.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PARA vs. PFE — Risk / Return Rank
PARA
PFE
PARA vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Paramount Global Class B (PARA) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading graphics...
Sharpe Ratios by Period
| PARA | PFE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 0.71 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.01 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.18 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | 0.26 | — |
Correlation
The correlation between PARA and PFE is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
PARA vs. PFE - Dividend Comparison
PARA's dividend yield for the trailing twelve months is around 0.45%, less than PFE's 6.13% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PARA Paramount Global Class B | 0.45% | 0.91% | 1.91% | 2.64% | 5.69% | 3.18% | 2.58% | 1.86% | 1.65% | 1.22% | 1.04% | 1.27% |
PFE Pfizer Inc. | 6.13% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Drawdowns
PARA vs. PFE - Drawdown Comparison
Loading graphics...
Drawdown Indicators
| PARA | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -58.96% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -12.59% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -58.96% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -58.96% | — |
Current DrawdownCurrent decline from peak | — | -42.75% | — |
Average DrawdownAverage peak-to-trough decline | — | -17.33% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 6.13% | — |
Volatility
PARA vs. PFE - Volatility Comparison
Loading graphics...
Volatility by Period
| PARA | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 6.75% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 18.50% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 26.73% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 25.46% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 23.90% | — |
Financials
PARA vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Paramount Global Class B and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PARA vs. PFE - Profitability Comparison
PARA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Paramount Global Class B reported a gross profit of 1.98B and revenue of 8.15B. Therefore, the gross margin over that period was 24.3%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a gross profit of 12.29B and revenue of 17.56B. Therefore, the gross margin over that period was 70.0%.
PARA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Paramount Global Class B reported an operating income of 207.00M and revenue of 8.15B, resulting in an operating margin of 2.5%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported an operating income of 3.69B and revenue of 17.56B, resulting in an operating margin of 21.0%.
PARA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Paramount Global Class B reported a net income of -573.00M and revenue of 8.15B, resulting in a net margin of -7.0%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a net income of -1.65B and revenue of 17.56B, resulting in a net margin of -9.4%.